BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26120792)

  • 1. Recent Changes in the Clinical Outcome of Papillary Thyroid Carcinoma With Cervical Lymph Node Metastasis.
    Jeon MJ; Kim WG; Choi YM; Kwon H; Song DE; Lee YM; Sung TY; Yoon JH; Hong SJ; Baek JH; Lee JH; Ryu JS; Kim TY; Shong YK; Chung KW; Kim WB
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3470-7. PubMed ID: 26120792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shear wave elastography in evaluation of cervical lymph node metastasis of papillary thyroid carcinoma: elasticity index as a prognostic implication.
    Jung WS; Kim JA; Son EJ; Youk JH; Park CS
    Ann Surg Oncol; 2015 Jan; 22(1):111-6. PubMed ID: 24740830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.
    Song E; Jeon MJ; Park S; Kim M; Oh HS; Song DE; Kim WG; Kim WB; Shong YK; Kim TY
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):123-128. PubMed ID: 28906015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of minimal extrathyroidal extension with pathologic features of lymph node metastasis in patients with papillary thyroid carcinoma.
    Lee HS; Park C; Kim SW; Park T; Chun BK; Hong JC; Lee KD
    J Surg Oncol; 2015 Nov; 112(6):592-6. PubMed ID: 26421594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
    Shindo M; Wu JC; Park EE; Tanzella F
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
    Roh JL; Kim JM; Park CI
    Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
    Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
    Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia.
    Cho SY; Lee TH; Ku YH; Kim HI; Lee GH; Kim MJ
    Surgery; 2015 Jan; 157(1):111-8. PubMed ID: 25444224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central lymph node metastasis in cN0 papillary thyroid carcinoma.
    Wu Y; Gu J; Shang J; Wang W; Wang K
    J BUON; 2013; 18(3):733-8. PubMed ID: 24065492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
    Kang JG; Choi JE; Kang SH
    World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
    Leboulleux S; Rubino C; Baudin E; Caillou B; Hartl DM; Bidart JM; Travagli JP; Schlumberger M
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5723-9. PubMed ID: 16030160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer.
    Bardet S; Ciappuccini R; Quak E; Rame JP; Blanchard D; de Raucourt D; Babin E; Michels JJ; Vaur D; Heutte N
    J Clin Endocrinol Metab; 2015 Jan; 100(1):132-40. PubMed ID: 25303481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
    Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
    J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma.
    Kwon H; Kim WG; Sung TY; Jeon MJ; Song DE; Lee YM; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
    J Surg Oncol; 2016 Feb; 113(2):152-8. PubMed ID: 26799259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.